Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men
Authors:
- Paul M RidkerPRPaul M Ridker
- Charles H HennekensCHCharles H Hennekens
- Beatrice Roitman-JohnsonBRBeatrice Roitman-Johnson
- Meir J StampferMSMeir J Stampfer
- Jean AllenJAJean Allen
- 1 January 1998
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 351 (9096) , 88-92
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Circulating Vascular Cell Adhesion Molecule-1 Correlates With the Extent of Human Atherosclerosis in Contrast to Circulating Intercellular Adhesion Molecule-1, E-Selectin, P-Selectin, and ThrombomodulinArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Molecular Identification of a Novel Fibrinogen Binding Site on the First Domain of ICAM-1 Regulating Leukocyte-Endothelium BridgingJournal of Biological Chemistry, 1997
- Cell adhesion molecules in coronary artery diseaseJACC, 1994
- ENDOTHELIAL-LEUKOCYTE ADHESION MOLECULES IN HUMAN DISEASEAnnual Review of Medicine, 1994
- The expression of the adhesion molecules ICAM‐1, VCAM‐1, PECAM, and E‐selectin in human atherosclerosisThe Journal of Pathology, 1993
- Endogenous tissue-type plasminogen activator and risk of myocardial infarctionThe Lancet, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cellsBiochemical and Biophysical Research Communications, 1992
- Endothelial Expression of a Mononuclear Leukocyte Adhesion Molecule During AtherogenesisScience, 1991
- Adhesion receptors of the immune systemNature, 1990